Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Comparative incidence and excess risk of acute kidney injury in hospitalised patients receiving vancomycin and piperacillin/tazobactam in combination or as monotherapy.

Carreno J, Smiraglia T, Hunter C, Tobin E, Lomaestro B.

Int J Antimicrob Agents. 2018 Nov;52(5):643-650. doi: 10.1016/j.ijantimicag.2018.08.001. Epub 2018 Aug 10.

PMID:
30103003
2.

Multicenter evaluation of IV acyclovir use prior to, during, and after a national shortage.

McLaughlin MM, Carreno JJ, Harpe SE, Jensen AO, Lomaestro B, Esterly JS.

Infect Dis (Lond). 2017 Oct;49(10):778-780. doi: 10.1080/23744235.2017.1325002. Epub 2017 May 17. No abstract available.

PMID:
28513239
3.

Pilot Study of a Bayesian Approach To Estimate Vancomycin Exposure in Obese Patients with Limited Pharmacokinetic Sampling.

Carreno JJ, Lomaestro B, Tietjan J, Lodise TP.

Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e02478-16. doi: 10.1128/AAC.02478-16. Print 2017 May.

4.

Assessment of Time to Clinical Response in Patients with Sepsis Treated Before and After Implementation of a Matrix-Assisted Laser Desorption Ionization Time-of-Flight Blood Culture Identification Algorithm.

Carreno JJ, Lomaestro BM, Jacobs AL, Meyer RE, Evans A, Montero CI.

Infect Control Hosp Epidemiol. 2016 Aug;37(8):916-23. doi: 10.1017/ice.2016.105. Epub 2016 Jun 9. Erratum in: Infect Control Hosp Epidemiol. 2016 Sep;37(9):1134.

PMID:
27277136
5.

Optimizing the initial amikacin dosage in adults.

White BP, Lomaestro B, Pai MP.

Antimicrob Agents Chemother. 2015 Nov;59(11):7094-6. doi: 10.1128/AAC.01032-15. Epub 2015 Aug 17.

6.

Vancomycin-associated renal dysfunction: where are we now?

Carreno JJ, Kenney RM, Lomaestro B.

Pharmacotherapy. 2014 Dec;34(12):1259-68. doi: 10.1002/phar.1488. Epub 2014 Sep 15. Review.

PMID:
25220436
7.

MenHibrix: a new combination meningococcal vaccine for infants and toddlers.

Hale SF, Camaione L, Lomaestro BM.

Ann Pharmacother. 2014 Mar;48(3):404-11. doi: 10.1177/1060028013514375. Epub 2013 Dec 18. Review.

PMID:
24353263
8.

Vancomycin dosing in children and young adults: back to the drawing board.

Camaione L, Elliott K, Mitchell-Van Steele A, Lomaestro B, Pai MP.

Pharmacotherapy. 2013 Dec;33(12):1278-87. doi: 10.1002/phar.1345. Epub 2013 Sep 9.

PMID:
24019205
9.

Population pharmacokinetics of extended-infusion piperacillin-tazobactam in hospitalized patients with nosocomial infections.

Felton TW, Hope WW, Lomaestro BM, Butterfield JM, Kwa AL, Drusano GL, Lodise TP.

Antimicrob Agents Chemother. 2012 Aug;56(8):4087-94. doi: 10.1128/AAC.00521-12. Epub 2012 May 14.

10.

Vancomycin dosing and monitoring 2 years after the guidelines.

Lomaestro BM.

Expert Rev Anti Infect Ther. 2011 Jun;9(6):657-67. doi: 10.1586/eri.11.46. Review.

PMID:
21692671
11.

Vancomycin: we can't get there from here.

Patel N, Pai MP, Rodvold KA, Lomaestro B, Drusano GL, Lodise TP.

Clin Infect Dis. 2011 Apr 15;52(8):969-74. doi: 10.1093/cid/cir078.

PMID:
21460308
12.
13.

Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.

Lodise TP, Patel N, Lomaestro BM, Rodvold KA, Drusano GL.

Clin Infect Dis. 2009 Aug 15;49(4):507-14. doi: 10.1086/600884.

PMID:
19586413
14.

Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists.

Rybak MJ, Lomaestro BM, Rotschafer JC, Moellering RC, Craig WA, Billeter M, Dalovisio JR, Levine DP.

Clin Infect Dis. 2009 Aug 1;49(3):325-7. doi: 10.1086/600877. Erratum in: Clin Infect Dis. 2009 Nov 1;49(9):1465.

PMID:
19569969
15.

Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.

Rybak M, Lomaestro B, Rotschafer JC, Moellering R Jr, Craig W, Billeter M, Dalovisio JR, Levine DP.

Am J Health Syst Pharm. 2009 Jan 1;66(1):82-98. doi: 10.2146/ajhp080434. Review. No abstract available. Erratum in: Am J Health Syst Pharm. 2009 May 15;66(10):887.

PMID:
19106348
16.

Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin.

Lodise TP, Graves J, Evans A, Graffunder E, Helmecke M, Lomaestro BM, Stellrecht K.

Antimicrob Agents Chemother. 2008 Sep;52(9):3315-20. doi: 10.1128/AAC.00113-08. Epub 2008 Jun 30.

17.

Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity.

Lodise TP, Lomaestro B, Graves J, Drusano GL.

Antimicrob Agents Chemother. 2008 Apr;52(4):1330-6. doi: 10.1128/AAC.01602-07. Epub 2008 Jan 28.

18.

Effects of gatifloxacin and levofloxacin on rates of hypoglycemia and hyperglycemia among elderly hospitalized patients.

Lodise T, Graves J, Miller C, Mohr JF, Lomaestro B, Smith RP.

Pharmacotherapy. 2007 Nov;27(11):1498-505.

PMID:
17963459
19.

Update on the pharmacotherapy of obesity. 1998.

Cerulli J, Lomaestro BM, Malone M.

Ann Pharmacother. 2007 Sep;41(9):1505-17. Epub 2007 Aug 14. Review. No abstract available.

PMID:
17698892
20.

Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection.

Lodise TP Jr, Patel N, Kwa A, Graves J, Furuno JP, Graffunder E, Lomaestro B, McGregor JC.

Antimicrob Agents Chemother. 2007 Oct;51(10):3510-5. Epub 2007 Jul 23.

21.

Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy.

Lodise TP Jr, Lomaestro B, Drusano GL.

Clin Infect Dis. 2007 Feb 1;44(3):357-63. Epub 2007 Jan 2.

PMID:
17205441
22.

Clinical prediction tool to identify patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk for multidrug resistance.

Lodise TP, Miller CD, Graves J, Furuno JP, McGregor JC, Lomaestro B, Graffunder E, McNutt LA.

Antimicrob Agents Chemother. 2007 Feb;51(2):417-22. Epub 2006 Dec 11.

23.

Application of antimicrobial pharmacodynamic concepts into clinical practice: focus on beta-lactam antibiotics: insights from the Society of Infectious Diseases Pharmacists.

Lodise TP, Lomaestro BM, Drusano GL; Society of Infectious Diseases Pharmacists.

Pharmacotherapy. 2006 Sep;26(9):1320-32. Review.

PMID:
16945055
24.

The spread of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae to upstate New York.

Lomaestro BM, Tobin EH, Shang W, Gootz T.

Clin Infect Dis. 2006 Aug 1;43(3):e26-8. Epub 2006 Jun 19.

PMID:
16804837
25.

Progressive esophagitis caused by Candida albicans with reduced susceptibility to caspofungin.

Miller CD, Lomaestro BW, Park S, Perlin DS.

Pharmacotherapy. 2006 Jun;26(6):877-80.

PMID:
16716141
26.
27.

Pharmacodynamic profiling of piperacillin in the presence of tazobactam in patients through the use of population pharmacokinetic models and Monte Carlo simulation.

Lodise TP Jr, Lomaestro B, Rodvold KA, Danziger LH, Drusano GL.

Antimicrob Agents Chemother. 2004 Dec;48(12):4718-24.

28.

Resistance to linezolid. Are we surprised? How hard should we look?

Lomaestro BM.

Ann Pharmacother. 2003 Jun;37(6):909-11. Review. No abstract available.

PMID:
12773084
30.

Bioterrorism: pivotal clinical issues. Consensus review of the Society of Infectious Diseases Pharmacists.

Terriff CM, Schwartz MD, Lomaestro BM; Society of Infectious Diseases Pharmacists.

Pharmacotherapy. 2003 Mar;23(3):274-90. Review.

PMID:
12627924
31.

Concomitant administration of drugs known to decrease the systemic availability of gatifloxacin.

Bowes J, Graffunder EM, Lomaestro B, Venezia RA.

Pharmacotherapy. 2002 Jun;22(6):800-1. No abstract available.

PMID:
12066975
32.

Therapeutic interchange of fluoroquinolones at a medical center.

Lomaestro BM.

Am J Health Syst Pharm. 2001 May 15;58(10):904-7. No abstract available.

PMID:
11381495
33.

Fluoroquinolone-induced renal failure.

Lomaestro BM.

Drug Saf. 2000 Jun;22(6):479-85. Review.

PMID:
10877041
34.

Hypersensitivity to intravenous and oral calcitriol with successful desensitization.

Amandeep S, Lomaestro B, Meuwissen HJ.

J Allergy Clin Immunol. 1999 Jan;103(1 Pt 1):176. No abstract available.

PMID:
9893204
35.

Streptogramins and their potential role in geriatric medicine.

Lomaestro BM, Briceland LL.

Drugs Aging. 1998 Dec;13(6):443-65. Review.

PMID:
9883400
36.

Update on drug interactions with azole antifungal agents.

Lomaestro BM, Piatek MA.

Ann Pharmacother. 1998 Sep;32(9):915-28. Review.

PMID:
9762380
37.

Update on the pharmacotherapy of obesity.

Cerulli J, Lomaestro BM, Malone M.

Ann Pharmacother. 1998 Jan;32(1):88-102. Review.

PMID:
9475827
38.

Medication-prescribing errors in a teaching hospital. A 9-year experience.

Lesar TS, Lomaestro BM, Pohl H.

Arch Intern Med. 1997 Jul 28;157(14):1569-76.

PMID:
9236558
39.

Quinupristin-dalfopristin (RP 59500): an injectable streptogramin combination.

Griswold MW, Lomaestro BM, Briceland LL.

Am J Health Syst Pharm. 1996 Sep 1;53(17):2045-53.

PMID:
8870891
40.

Outcomes assessment of drug treatment in multiple sclerosis clinical trials.

Malone M, Lomaestro B.

Pharmacoeconomics. 1996 Mar;9(3):198-210. Review.

PMID:
10160097
41.

Glutathione in health and disease: pharmacotherapeutic issues.

Lomaestro BM, Malone M.

Ann Pharmacother. 1995 Dec;29(12):1263-73. Review.

PMID:
8672832
42.

Dosing adjustment of 10 antimicrobials for patients with renal impairment.

Preston SL, Briceland LL, Lomaestro BM, Lesar TS, Bailie GR, Drusano GL.

Ann Pharmacother. 1995 Dec;29(12):1202-7.

PMID:
8672821
43.

Absorption interactions with fluoroquinolones. 1995 update.

Lomaestro BM, Bailie GR.

Drug Saf. 1995 May;12(5):314-33. Review.

PMID:
7669261
44.

More on the GUSTO Trial.

Lomaestro BM.

Ann Intern Med. 1994 Nov 15;121(10):818-9. No abstract available.

PMID:
7944069
45.

Continuing problem of ciprofloxacin administered with interacting drugs.

Lomaestro BM, Lesar TS.

Am J Hosp Pharm. 1994 Mar 15;51(6):832. No abstract available.

PMID:
8010328
46.

Effect of multiple staggered doses of calcium on the bioavailability of ciprofloxacin.

Lomaestro BM, Bailie GR.

Ann Pharmacother. 1993 Nov;27(11):1325-8.

PMID:
8286801
47.

Timeliness of medication administration in hemodialysis inpatients: drug use evaluation.

Lomaestro BM, Bailie GR, Eisele G.

Hosp Pharm. 1993 Oct;28(10):980-2, 984.

PMID:
10129141
48.

Pleurodesis with solution prepared from quinacrine hydrochloride tablets.

Lomaestro BM, Lesar TS, Kaslovsky RA.

Clin Pharm. 1993 Sep;12(9):693-5. No abstract available.

PMID:
8306569
49.

Errors in prescribing methotrexate.

Lomaestro BM, Lesar TS, Hager TP.

JAMA. 1992 Oct 21;268(15):2031-2. No abstract available.

PMID:
1404735
50.

Relationship between peritonitis and exit site infections in CAPD.

Eisele G, Bailie GR, Lomaestro B.

Adv Perit Dial. 1992;8:227-9.

PMID:
1361793

Supplemental Content

Loading ...
Support Center